T0	Participants 35 90	patients with newly diagnosed type 1 diabetes mellitus.
T1	Participants 122 164	18 patients with Type 1 diabetes mellitus.
T2	Participants 165 304	All were participating in the Canadian-European randomized placebo-controlled cyclosporin trial in newly diagnosed Type 1 diabetic patients